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Bone marrow transplantation attenuates murine IgA nephrop- fined by the deposition of IgA in glomerular mesangium
athy: Role of a stem cell disorder. [1, 2]. IgA nephropathy was initially considered to be a
Background. The pathogenesis of IgA nephropathy is still benign disease until it was recognized that a consistentobscure. The aim of this study was to investigate whether the
percentage of the patients, despite standard therapy, hadfundamental pathogenesis of IgA nephropathy lies in bone
a progressive course leading to end-stage renal diseasemarrow stem cells (BMCs).
Methods. We used donors of two different strains for bone (ESRD) requiring dialysis [3–5]. Although the pathogene-
marrow transplantation (BMT) into mice with a high content sis of IgA nephropathy is still obscure, some immunologi-
of serum IgA (ddY strain, HIGA mice), a murine model of
cal dysfunction seems to play an important role [5–9].IgA nephropathy. One group (B6→HIGA, N 5 5) received
In some patients with IgA nephropathy who presentedBMCs of C57BL/6j (B6) mice, and the other (HIGA→HIGA,
N 5 8) were reconstituted with BMCs of HIGA mice. with ESRD and subsequently were transplanted with
Results. Twenty-six weeks after BMT, in B6→HIGA mice, healthy kidneys, IgA nephropathy recurred in the grafts
mesangial deposits of IgA and C3 were statistically milder than [10]. Additionally, when a kidney with mesangial IgA
those in HIGA→HIGA mice. Light microscopic observations
deposits was inadvertently transplanted into a patientdisclosed that glomerular sclerosis and mesangial matrix expan-
whose ESRD was unrelated to IgA nephropathy, thesion in B6→HIGA mice were decreased compared with those
in HIGA→HIGA mice. These B6→HIGA mice also excreted deposits disappeared [11]. These examples indicate that
less urinary albumin than HIGA→HIGA mice. Furthermore, an intrinsic circulating factor(s), rather than an intrinsic
serum levels of IgA in B6→HIGA mice were markedly lower defect(s) of the kidney, caused the IgA deposition in thethan those in HIGA→HIGA mice. Size analysis of serum IgA
mesangial area.revealed that macromolecular IgA were notably lower in
Recently, we encountered a patient with IgA nephrop-B6→HIGA mice than in HIGA→HIGA mice.
Conclusions. Our results suggest that qualitative and quanti- athy and chronic myeloblastic leukemia whose bone mar-
tative changes of serum IgA are determined at the level of row transplantation (BMT) not only cured the leukemia,
stem cells, and that BMT from normal donors can attenuate but also eliminated the mesangial IgA deposits (abstract;glomerular lesions in HIGA mice. This approach may offer a
Sakai, Nephrology 3:2–3, 1997). This exciting observationnew avenue to study the pathogenesis of IgA nephropathy.
provided the first evidence suggesting that abnormalities
of bone marrow stem cells (BMCs) may be involved in
the pathogenesis of IgA nephropathy and that BMTImmunoglobulin A (IgA) nephropathy is the most fre-
from a normal donor might have attenuated glomerularquently presented form of glomerulonephritis, and is de-
lesions in our patient. However, some possibility remains
that the immunosuppressant used for our patient may
1 See Editorial, p. 1964. have effected the renal recovery.
In the present study, we employed a murine model ofKey words: hematopoietic stem cells, glomerulonephritis, immuno-
globulin A, transplantion immunology. IgA nephropathy, high serum IgA ddY (HIGA) mouse,
whose mesangial IgA deposition spontaneously becameReceived for publication February 18, 1999
apparent by approximately 25 weeks of age [12]. Theand in revised form May 28, 1999
Accepted for publication June 29, 1999 mesangial IgA deposition became more marked with age,
and expansion of the mesangial area with electron-dense 1999 by the International Society of Nephrology
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deposits was also observed [12]. In sera of HIGA mice, mens for immunohistopathology were embedded in
OCT compound (Miles Scientific, Napperville, IL, USA)macromolecular IgA was increased [12]. Similarly, an
increase of serum IgA, especially macromolecular IgA, and quickly frozen in dry ice and acetone. Spleen cells
were subjected to immunocytological analysis on the daywas observed in patients with IgA nephropathy [13].
Macromolecular IgA was considered to be one candidate of sacrifice.
of circulating factors to have a pivotal role in the patho-
Irradiation and T-cell–depleted bone marrow cellsgenesis of human IgA nephropathy [6, 9]. Therefore, the
HIGA mouse is an appropriate model in which to study Preliminary experiments showed that a single 8.5 Gy
dose of total body irradiation from a 60Co source killedthe pathogenesis of IgA nephropathy.
To investigate whether the pathogenic agent of IgA ne- all HIGA mice by three weeks after the irradiation if
subsequent BMT was not carried out. In spleens of thesephropathy lies in BMCs and, accordingly, whether BMT
might be a tool for treating IgA nephropathy, HIGA irradiated mice, no hematopoietic colonies were visible
macroscopically 14 days after irradiation, indicating thatmice (23 to 25 weeks of age) received BMCs from donors
of two strains: normal C57BL/6j (B6) mice (25-week-old) no pluripotential stem cells were present [14]. Con-
versely, autologous BMT rescued all HIGA mice ex-and syngeneic HIGA mice (27-week-old). The results
suggest that serum levels of IgA, mainly macromolecular posed to 8.5 Gy without side effects such as gastrointesti-
nal bleeding or infection. Based on these results, allIgA, may be determined by a factor(s) in BMCs that
can cause IgA nephropathy and, consequently, that BMT recipient HIGA mice were irradiated with 8.5 Gy.
Bone marrow cells from pelvis, femoral, and peronealhave a beneficial effect on murine IgA nephropathy.
bones were incubated with anti–Thy-1.2 Ab (F7D5; Ser-
otec Ltd., Oxford, UK) at a 1:1000 dilution on ice for
METHODS
30 minutes and then reacted with rabbit complement
Mice (Cedar Lane, Ontario, Canada) at 378C for 30 minutes.
Preliminary studies confirmed that this procedure elimi-Female HIGA mice were obtained from Nippon Shin-
yaku Co. Ltd. (Kyoto, Japan). Female B6 mice were nated more than 98% of the T cells, as revealed by
immunofluorescent staining.purchased from Japan Sankyo Labo Service Corpora-
tion, Inc. (Tokyo, Japan). All of the animals were main-
FACS analysistained on autoclaved standard laboratory chow under
specific pathogen-free conditions in the animal facility Spleen cells were gently homogenized and depleted
of red blood cells by Tris-buffered ammonium chlorideat Tokyo Metropolitan Institute of Gerontology. All sur-
gical procedures conformed to the guidelines established (pH 7.2). To prevent nonspecific binding of Abs to Fcg
receptors, spleen cells were incubated with purifiedby the U.S. Department of Health and Human Services,
as published by the National Institutes of Health (NIH mouse IgG (Zymed Laboratories, Inc., San Francisco,
CA, USA) on ice for 30 minutes. After washing, phycoer-publication no. 85-23, revised 1985).
ythrin-conjugated monoclonal mouse anti-H-2Db Ab
Experimental protocol (Pharmingen, San Diego, CA, USA) was reacted with
the pretreated cells on ice for 30 minutes. Then cellsOne week before BMT (pre-BMT), serum and urine
were obtained from recipient HIGA mice (22 to 24 weeks were resuspended in 1% paraformaldehyde containing
0.1% azide. Stained cells were analyzed by FACScanof age), and then, after anesthesia with pentobarbital,
approximately 2 mm cubes of renal sections were re- (EPICS CS; Coulter Electronics, Hialeah, FL, USA).
moved surgically. On the day of cell transfusion, recipi-
Histopathological analysisents were lethally irradiated (8.5 Gy/mouse) and then
divided into two groups: One group (designated as For light microscopy, tissues embedded in paraffin were
stained with periodic acid-Schiff (PAS) reagent. For as-B6→HIGA, N 5 5) received BMCs of 25-week-old B6
mice, and the other (designated as HIGA→HIGA, N 5 8) sessment of histological changes, the frequency of glo-
bally or segmentally sclerosed glomeruli was calculatedwere reconstituted with BMCs of 27-week-old HIGA
mice. Five to six hours after irradiation, recipient HIGA in each section by dividing the number of affected glo-
meruli by the total number of glomeruli. The extent inmice (23 to 25 weeks of age) were injected intravenously
with respective 1 3 107 T-cell–depleted BMCs. From six mesangial matrix increase was assessed for each glomer-
ulus by scoring from 0 to 3: 0 5 normal, 1 5 mildweeks after transplantation, we obtained serum samples
every four weeks. Twenty-six weeks after the reconstitu- (,one third of glomerular tuft area), 2 5 moderate
(,two thirds of glomerular tuft area), and 3 5 severetion (approximately 50-week-old, post-BMT), all mice
were sacrificed to obtain serum, urine, kidney specimens, (.two thirds of glomerular tuft area). The glomeruli
were scored in the average of 56 glomeruli (range, 22 toand spleen cells. Serum and urine samples for immuno-
logical assay were kept at 2808C until use. Kidney speci- 102 glomeruli) cross sections per specimen, and a value
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Fig. 1. FACS analysis of lymphocytes in spleens
26 weeks after bone marrow transplantation
(BMT). Splenic lymphocytes depleted of red
blood cells were stained with anti–H-2Db anti-
bodies (Ab) and were then subjected to FACS.
Results represent (A) 50-week-old B6 mouse,
(B) 50-week-old HIGA mouse, (C) B6→HIGA
mouse 26 weeks after BMT, and (D) HIGA→
HIGA mouse 26 weeks after BMT.
for each individual animal represents an averaged score Enzyme-linked immunosorbent assay
in each section. Concentrations of mouse immunoglobulins were mea-
Cryostat sections were cut 4 mm thick and fixed in sured by enzyme-linked immunosorbent assay (ELISA)
cold acetone for 10 minutes. For direct immunofluores- as follows. Ninety-six-well plates (IMMULON 2; Dynex
cence, the sections were stained with fluorescein isothio- Technologies, Inc., Chantilly, VA, USA) had been pre-
cyanate (FITC)-labeled goat anti-mouse IgA, IgG, IgM, viously coated with goat affinity-purified antimouse im-
and complement C3 Abs (Cappel Research Products, munoglobulin Abs (Cappel Research Products). After
Durham, NC, USA) appropriately diluted in phosphate- reacting with PBS containing 1% skim milk powder to
block nonspecific reactivity of sera, the plates were incu-buffered saline (PBS) at 378C for one hour. Immunohis-
bated with appropriately diluted samples and immuno-topathological analysis was carried out under a Zeiss
globulin reference sera (ICN Pharmaceuticals Inc., CostaAxiophot fluorescence photomicroscope. The relative
Mesa, CA, USA) and then washed with PBS containingamount of staining was scored semiquantitatively as fol-
0.05% Tween20 (PBS/Tween). Adsorbed immunoglobu-lows [12]: 0 5 negative staining, 1 5 slight (focal and
lin was incubated with peroxidase-labeled goat antimouseweak) staining, 2 5 moderate staining, and 3 5 marked
immunoglobulin Ab (Zymed Laboratories). After wash-(diffuse and intense) staining. More than 20 glomeruli
ing with PBS/Tween, the residual peroxidase was reactedper specimen were scored in this manner, and the mean
with TMB peroxidase substrate (Kirkegaard & Perry Lab-was calculated by the total score of affected glomeruli
oratories Inc., Gaithersburg, MD, USA) according toby the total number of glomeruli as fluorescent intensity
manufacturer’s instructions. Absorbance in each well was(FI) in each individual animal.
measured with a MTP-100 microplate reader (Corona
Electric Co., Tokyo, Japan) at a wavelength of 450 nm.Urinary albumin concentration
Concentrations of excreted urinary albumin were de- Fast protein, peptide, and polynucleotide
termined by the single radial immunodiffusion method liquid chromatography
(SRID) [15]. In brief, urine samples and a mouse albumin Ten-times diluted serum samples pooled from mice of
reference (Cappel Research Products) as a standard were each group were subjected to the fast protein, peptide,
applied to wells on agarose gel-containing polyclonal and polynucleotide liquid chromatography (FPLC) sys-
rabbit anti-mouse albumin Ab (Cappel Research Prod- tem (Pharmacia, Uppsala, Sweden) on a Superdex 200
ucts). By this method, we could minimally detect 60 HR 10/30 (Pharmacia). Molecular weight markers were
mg/ml of mouse albumin. Because many samples were thyroglobulin (669 kDa) and aldolase (158 kDa; Phar-
in an undetectable range, excreted urinary albumin con- macia). Samples were applied to the FPLC column at a
centrations measured by SRID were grouped for the flow rate of 0.4 ml/min, and fractionated samples were
statistical analysis as 0, 0 to 99 mg/ml; 1, 100 to 199 mg/ml; collected every one minute in 0.1 m phosphate buffer,
pH 7.0, containing 0.1 m NaCl.2, 200 to 299 mg/ml; and 3, 300 to 399 mg/ml.
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Fig. 4. Representative microscopic photographs in renal tissues at post-Fig. 2. Representative immunofluorescence photographs of IgA stain-
BMT (PAS staining, original magnification 3400). (A) Glomeruli ining in renal tissues (original magnification 3200) of (A) B6→HIGA
B6→HIGA mouse showed a normal appearance. (B) In contrast, glo-mouse at post-BMT and (B) HIGA→HIGA mouse at post-BMT. Fro-
meruli in the HIGA→HIGA mouse had severe mesangial matrix expan-zen sections were stained directly with FITC-labeled antimouse IgA
sion and segmental glomerulosclerosis.Ab. At post-BMT, glomeruli in B6→HIGA mice showed weak IgA
deposition. In contrast, HIGA→HIGA mice at post-BMT had global,
diffuse mesangial IgA deposits.
anti–H-2Db Ab and then analyzed by FACS. Lympho-
Statistical analysis cytes of nontransplanted B6 mice, whose MHC class I
was H-2Db, showed positive staining (Fig. 1A), whereasAll values are expressed as means 6 sem. The two-
lymphocytes in HIGA mice, whose MHC type has notgroup paired t-test was used to compare the changes of
yet been determined, were negative for H-2Db (Fig. 1B).histology at pre- and post-BMT in each individual ani-
This method enabled us to recognize whether lympho-mal; the unpaired t-test was used to analyze ELISA and
cytes in recipients were B6 or HIGA in origin. Accord-histology data between transplanted animals, and the
ingly, lymphocytes in HIGA mice received BMCs ofMann–Whitney test was used to compare urinary data.
B6 mice (B6→HIGA) were positive like those of B6A P value of less than 0.05 was considered statistically
mice (Fig. 1C). HIGA recipients of BMCs of HIGAsignificant.
mice (HIGA→HIGA) had H-2Db-negative lymphocytes
(Fig. 1D). Thus, BMCs transferred to B6→HIGA mice
RESULTS successfully replaced those of the HIGA type.
Donor bone marrow stem cells repopulated
Immunodeposition decreased in glomeruli ofin recipients
B6→HIGA miceTo confirm that BMCs from each donor successfully
Because BMCs of B6→HIGA mice originated fromrepopulated in recipients, H-2 typing was performed 26
weeks after BMT. Splenic lymphocytes were stained with B6 mice, we next examined mesangial depositions of
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Fig. 3. Comparison of mesangial immunofluo-
rescent intensity and mesangial matrix expansion
scores before and after BMT. (A) IgA staining
in B6→HIGA mice (N 5 5). (B) IgA staining in
HIGA→HIGA mice (N 5 8). (C) C3 staining in
B6→HIGA mice. (D) C3 staining in HIGA→
HIGA mice. (E) Mesangial matrix expansion
scores of B6→HIGA mice. (F ) Mesangial matrix
expansion scores of HIGA→HIGA mice. Bars
are means 6 sem. Renal sections biopsied before
and 26 weeks after BMT were stained for IgA
and C3, followed by scoring more than 20 glomer-
uli per section and calculating the values of FI as
described in the Methods section. The degree of
mesangial matrix expansion was semiquantita-
tively calculated as detailed there. P values are
indicated between pre- and post-BMT in each
group (paired t-test) or between B6→HIGA mice
at post-BMT and HIGA→HIGA mice at post-
BMT (unpaired t-test).
immunoglobulins and C3 by immunofluorescent stain- The degree of mesangial IgA depositions in B6→HIGA
mice at post-BMT was as same as those in nontrans-ing. At the post-BMT period (26 weeks after BMT; when
mice were approximately 50 weeks old), mesangial depo- planted normal B6 mice at the age of 50 weeks (1.34 6
0.32). In sharp contrast, all HIGA→HIGA mice hadsition of IgA was weak in B6→HIGA mice (Fig. 2A).
At the same time, IgA deposits in HIGA→HIGA mice much higher FI scores for mesangial IgA deposition at
post-BMT than those at pre-BMT (2.49 6 0.16 vs. 0.84 6were observed diffusely and globally in the mesangial
area (Fig. 2B). 0.05, P , 0.0001; Fig. 3B). It should be noted that FI
scores of mesangial IgA deposition in nontransplantedWhen we then scored the intensity of fluorescence (FI),
mesangial IgA depositions in both B6→HIGA (N 5 5) HIGA mice at 50 weeks old were comparable to those
of post-BMT HIGA→HIGA mice (2.39 6 0.24). At post-and HIGA→HIGA (N 5 8) mice were similarly slight
at pre-BMT (one week before BMT; Fig. 3 A, B). In BMT, mesangial IgA depositions in B6→HIGA mice
were statistically milder than those in HIGA→HIGAB6→HIGA mice, the FI values of IgA depositions at
post-BMT were not statistically different from those at mice (P , 0.01) or age-matched HIGA mice. Clearly,
mesangial IgA depositions of B6→HIGA mice took apre-BMT (1.17 6 0.14 vs. 0.79 6 0.03, P . 0.05; Fig. 3A).
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turn for the better compared with those of HIGA→
HIGA mice or with nontransplanted HIGA mice.
Next, mesangial complement C3 deposition was ana-
lyzed because such deposits universally accompany hu-
man and murine IgA nephropathy [5, 12]. At pre-BMT,
mesangial depositions of C3 were seldom apparent in
either group of mice. In B6→HIGA mice, FI scores of
C3 at post-BMT were comparable to those at pre-BMT
(0.17 6 0.08 vs. 0.0 6 0.0, P . 0.05; Fig. 3C). However,
in HIGA→HIGA mice, scores of C3 deposits were con-
Fig. 5. Comparison of the concentration of urinary albumin. The con-siderably higher after than before BMT (1.08 6 0.25 vs. centration of albumin was measured by the single radial immunodiffu-
0.02 6 0.02, P , 0.01; Fig. 3D). FI scores of mesangial sion method and was then scored for statistical analysis. This figure
shows albuminuria in (A) B6→HIGA mice and in (B) HIGA→HIGAC3 depositions in B6→HIGA mice were statistically
mice at pre- and post-BMT.
lower than those in HIGA→HIGA mice (P , 0.05 at
post-BMT).
At post-BMT, mesangial depositions of IgG in B6→
HIGA mice were also milder than those in HIGA→ pre-BMT (,60 mg/ml; Fig. 5). However, at post-BMT,
HIGA mice without a statistically significant difference the scores of albuminuria in B6→HIGA mice were statis-
(1.28 6 0.32 vs. 1.80 6 0.21, P . 0.05), whereas mesangial tically lower than those from HIGA→HIGA mice (P ,
IgM depositions in B6→HIGA mice were the same as 0.05; Fig. 5). Therefore, in addition to ameliorating the
those in HIGA→HIGA mice (1.38 6 0.32 vs. 1.49 6 0.27). renal lesions, BMT also reduced albuminuria, an impor-
tant clinical feature of IgA nephropathy.
Glomerular sclerotic lesion and mesangial matrix
Serum IgA levels, which increase with age in HIGA mice,expansion diminished in B6→HIGA mice
were decreased by bone marrow transplantation fromBecause immunofluorescent staining revealed that BMT
B6 micefrom normal B6 mice attenuated mesangial IgA and C3
To investigate the immunological components partici-deposition in HIGA mice, this effect was analyzed with
pating in these effects of BMT, we next calculated serumlight microscopy. In both groups, no glomeruli had scle-
immunoglobulin levels by ELISA. Serum IgA levelsrotic lesions at pre-BMT. At post-BMT period, few glo-
(Fig. 6A) in B6→HIGA mice were much lower thanmeruli in B6→HIGA mice had sclerotic lesions. In fact,
those in HIGA→HIGA mice throughout the experimen-the frequency of glomerulosclerotic lesions in B6→
tal course after BMT (402 6 65 vs. 1519 6 93 mg/dl,HIGA mice (Fig. 4A) was significantly lower than that
P , 0.01 at post-BMT). However, serum IgM levelsin HIGA→HIGA mice (0.40 6 0.40 vs. 9.8 6 1.5%, P ,
(Fig. 6B) in B6→HIGA mice were significantly higher0.001; Fig. 4B). Next, we scored the degree of mesangial
than in HIGA→HIGA mice from 14 weeks after BMTmatrix expansion and calculated the values of matrix
(85.0 6 9.8 vs. 48.1 6 2.2 mg/day, P , 0.01 at post-expansion scores as described in the Methods section.
BMT). Serum IgG levels (Fig. 6C) in both groupsIn B6→HIGA recipients of BMT, scores at post-BMT
changed similarly throughout the experimental course
were not statistically higher than those at pre-BMT
(1128 6 79 vs. 1242 6 74 mg/dl, P . 0.05 at post-BMT).
(0.90 6 0.11 vs. 0.69 6 0.10, P . 0.05; Fig. 3E). Con-
versely, the mesangial matrix expansion scores of HIGA→ Bone marrow transplantation from B6 mice decreased
HIGA mice were considerably higher after than before serum macromolecular IgA of transplanted HIGA mice
BMT (1.49 6 0.10 vs. 0.76 6 0.06, P , 0.01; Fig. 3F). To assess the size of serum IgA as a determinant of
At post-BMT, the mesangial matrix expansion scores of mesangial deposition at post-BMT, IgA level in samples
B6→HIGA mice were statistically lower than those of fractionated by FPLC were measured by ELISA. Prelim-
HIGA→HIGA mice (P , 0.01). BMT from normal mice inary examination revealed that most of these IgA mole-
also improved the glomerular changes of HIGA mice, cules in nontransplanted HIGA mice at 25 and 50 weeks
as judged by light microscopy. of age were macromolecules (molecular weight .500
kDa). We also confirmed that macromolecular IgA was
Decreased concentration of excreted albuminuria not predominant in serum of normal B6 mice at 25 and
from B6→HIGA mice 50 weeks old. As in the HIGA mice, macromolecular
Next, we examined how these histological improve- IgA with a molecular weight of approximately 670 kDa
ments effected urinary albumin excretion. Albumin ex- predominated in HIGA→HIGA mice (Fig. 7). However,
in B6→HIGA mice, levels of macromolecular IgA werecretion from HIGA mice was virtually undetectable at
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Fig. 6. Serum immunoglobulin levels deter-
mined by ELISA for (A) IgA, (B) IgM, and
(C) IgG in B6→HIGA mice (d) and in
HIGA→HIGA mice (h). Values are means 6
sem; *P , 0.05 vs. HIGA→HIGA mice. Se-
rum samples were obtained before BMT and
every four weeks after BMT.
the origin of IgA nephropathy, our results showed clear-
cut reductions in mesangial IgA and complement C3 depo-
sition and a decrease in glomerular sclerotic lesions and
mesangial matrix expansion only in the recipients of B6
cells. These B6→HIGA mice also excreted less urinary
albumin than the HIGA→HIGA controls. Subsequent
analysis of immunological changes revealed that the serum
IgA level, especially macromolecular IgA, in B6→HIGA
mice was much lower than in HIGA→HIGA mice.
For successful BMT and efficient observation of its
effects, we needed a murine model in which mesangial
IgA deposition occurred by the 25th week of life. The
essential factors were that the thymus is considered crucial
to immunological reconstitution after BMT [16], but thy-
mic atrophy starts in mice at 25 weeks of age and worsens
drastically thereafter [17]. Because HIGA mice, which
originated from IgA nephropathy-prone ddY mice andFig. 7. Analysis of IgA size in sera from B6→HIGA mice (d) and
HIGA→HIGA mice (h). Serum samples collected from mice of each produce especially high levels of serum IgA, exhibited
group were fractionated by FPLC (0.4 ml/min, 1 ml/tube), and the mesangial IgA deposits at 25 weeks of age and these
concentrations of IgA in fractions were determined by ELISA. Mono-
deposits become more marked with age [12], we chosemeric IgA has been identified as about 160 kDa [24].
them for this study.
In general, T-cell–depleted BMCs are the cells used
in BMT [18, 19]. For the generation of naive T cells
markedly lower than in HIGA→HIGA mice and were capable of differentiating into antigen-specific T lympho-
equivalent to those of monomeric IgA with a molecular cytes through education in thymus, two to three months
weight of 160 kDa (Fig. 7). are required after BMT [20, 21]. In this study, 26 weeks
after the transplantation of T-cell–depleted BMCs, do-
DISCUSSION nor BMCs were successfully regenerated in recipients,
When we compared IgA nephropathy-prone HIGA and the cell surface phenotype of lymphocytes in B6→
mice transplanted with BMCs from normal B6 mice (B6→ HIGA mice completely changed from the HIGA type
to the B6 type (Fig. 1). Additionally, the IgG level inHIGA) to their counterparts given HIGA BMCs to probe
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B6→HIGA mice was comparable, and the IgM content ably because the B6→HIGA subjects had less macromo-
lecular IgA.was superior to that in HIGA→HIGA mice (Fig. 6)
Because BMCs transplanted into both B6→HIGAor age-matched, unmanipulated HIGA mice (data not
mice and HIGA→HIGA mice were equally exposed toshown). These findings contradict some reports that im-
the same environmental factors, the immunological dif-munodeficiency occasionally occurred in mice after le-
ferences in the two groups must come from variationsthal irradiation followed by transfer of multiple histo-
in the BMCs. Accordingly, qualitative and quantitativecompatibility complex-mismatched BMT [22]. In our
changes of serum IgA may be determined at the leveltransplant recipients, no immunological defect was evi-
of stem cells. In support of this notion, we have obtaineddent. Therefore, we considered it feasible to examine the
a result that BMT from IgA nephropathy-prone ddYrole of BMCs in the pathogenesis of IgA nephropathy by
mice to normal B6 mice increased the recipients’ serumanalyzing mice 26 weeks after BMT.
macromolecular IgA and glomerular IgA depositionAs a result of BMT, mesangial IgA depositions in
[33]. We do not deny the involvement of antigens in theB6→HIGA mice were statistically weaker than those in
pathogenesis of IgA nephropathy. However, we considerHIGA→HIGA mice or age-matched HIGA mice (Figs.
that the antigens may merely elicit the basic factor that2 and 3). Until now, mesangial IgA deposition has been
lies in BMCs. Still obscure is what factor(s) of BMCs,attributed to a high production of IgA [23], the presence
not of the environment, reduces macromolecular IgAof serum macromolecular IgA [6, 13], the defective clear-
in B6→HIGA mice. We speculate that bone marrow-ance of IgA [9], and abnormal cytokine production [8].
derived cells, such as T cells [7, 34, 35], B cells [36, 37],To pursue the study of factors that attenuate mesangial
Kupffer cells [9, 38–40] and mucosal intraepithelial cellsIgA deposition in B6→HIGA mice, we first analyzed
[5, 41, 42], may contribute to determine qualitative andthe nature of serum IgA in this model.
quantitative changes of serum IgA in HIGA mice andAs shown in Figure 6, serum IgA levels in B6→HIGA
that the defects of these cells might be determined atmice were much lower than in HIGA→HIGA mice.
the stem cell level. It was also thought that BMT fromOthers believe that not only in murine but also in human
normal donors improved the abnormalities of bone mar-IgA nephropathy, mesangial IgA deposition correlates
row-derived cells and attenuated the glomerular lesionsbetter with the amount of macromolecular IgA [13, 24,
in these mice. We are now attempting to clarify which25], because of the macromolecular form’s (a) reduced
of these cells and what factors are defective at the stemclearance from the circulation [9], (b) high affinity to
cell level and are most important for increasing serummesangial cell [6], and (c) enhancement of interleukin-6
levels of macromolecular IgA in IgA nephropathy.expression, which induces immunoglobulin class switch-
This study revealed that qualitative and quantitative
ing to IgA [26, 27]. For these reasons, we next analyzed
changes in serum IgA are determined at the level of
the molecular size of serum IgA in our model and found stem cells, and that disordered BMCs in mice with IgA
that serum macromolecular IgA levels in B6→HIGA nephropathy are responsible for high serum levels of
mice were notably lower than in HIGA→HIGA mice IgA, especially macromolecular IgA, enough to cause
(Fig. 6). Indeed, as reported in patients with AIDS, the glomerular lesions. Furthermore, our data implicate that
increment of macromolecular IgA was not necessarily BMT is therapeutically beneficial for murine IgA ne-
accompanied by mesangial IgA deposits [28, 29]. How- phropathy and warrants a pioneering approach to study
ever, it is quite possible that the marked decrement of the pathogenesis of IgA nephropathy.
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